- Home
- BSP vs VTRS Comparison
BSP vs VTRS Comparison
Compare BSP & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSP | VTRS |
|---|---|---|
| Founded | 2013 | 1961 |
| Country | Italy | United States |
| Employees | N/A | 30000 |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8B | 21.0B |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BSP | VTRS |
|---|---|---|
| Price | $46.50 | $18.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $47.67 | $19.70 |
| AVG Volume (30 Days) | 3.8M | ★ 8.3M |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $14,299,900,000.00 |
| Revenue This Year | $122.07 | $3.44 |
| Revenue Next Year | $47.05 | $1.68 |
| P/E Ratio | ★ N/A | $369.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.11 | $9.92 |
| 52 Week High | $59.50 | $18.75 |
Technical Indicators
Market Signals| Indicator | BSP | VTRS |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 61.61 |
| Support Level | $37.47 | $15.94 |
| Resistance Level | $46.94 | N/A |
| Average True Range (ATR) | 4.91 | 0.47 |
| MACD | 0.86 | 0.07 |
| Stochastic Oscillator | 53.96 | 83.86 |
Price Performance
Historical ComparisonAbout BSP Bending Spoons S.p.A. Ordinary Shares
Bending Spoons SpA acquires and operates digital businesses, focusing on business transformation and operational optimization. Its activities include acquiring companies, implementing operational improvements, and reinvesting in additional acquisitions. The company owns AOL, Brightcove, Eventbrite, Evernote, Harvest, Komoot, Meetup, Remini, StreamYard, Vimeo, and WeTransfer. The majority of revenue is derived from subscriptions, by selling term-based access to its products to individuals and organizations, and the rest from advertising and other sources.
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.